Screener
Agios Pharmaceuticals AGIO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Total assets | $1,108,424 | $1,297,225 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $16,345 | $18,355 |
| Accrued expenses | 34,647 | 45,459 |
| Operating lease liabilities | 19,225 | 18,392 |
| Total current liabilities | 70,217 | 82,206 |
| Operating lease liabilities, net of current portion | 11,946 | 21,815 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's accounts payable?
- Agios Pharmaceuticals (AGIO) reported accounts payable of $16.35M in Q2 2026.
- How has Agios Pharmaceuticals's accounts payable changed year-over-year?
- Agios Pharmaceuticals's accounts payable decreased by 6.8% year-over-year, from $17.53M to $16.35M.
- What is the long-term trend for Agios Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's accounts payable has grown at a -7.3% compound annual growth rate (CAGR), from $26.84M to $18.36M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Agios Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude